Healthcare company Haemonetics Corp. (HAE) on Tuesday affirmed its fiscal 2019 guidance for adjusted earnings in the range of $2.00 to $2.30 per share and constant currency revenue growth in the range of 3 to 5 percent.
from RTT - Earnings https://ift.tt/2vpjcO3
via IFTTT
No comments:
Post a Comment